“…However, they often require high-cost, bulky, and sophisticated equipment, trained operators, as well as toxic reagents. Moreover, the need of blood-based tests for high-volume and invasive blood sampling, and suffering the nonblood-based tests from low correlation with the results of blood-based tests and consequently their low accuracy and reliability limit the application of the developed sensors for on-site bilirubin monitoring. , There are also various commercial bilirubinometers with the ability to transcutaneously monitor bilirubin, which, despite being noninvasive and easy-to-use, have low accuracy, precision, and reliability compared to blood-based bilirubin detection methods . Thus, even today, on the eve of healthcare 5.0, in spite of significant progress in diagnostics, the development of efficient smart sensors capable of noninvasively monitoring bilirubin and diagnosing jaundice with high accuracy and reliability of bilirubin blood tests is still an unmet high demand. ,− This issue is of greater importance particularly at sites far from centralized laboratory facilities and point-of-care (POC) applications, where neonates blood sampling, preprocessing, and analyzing is accompanied by serious operational and equipment limitations/challenges …”